Argul Razbekova
Argul Razbekova has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ainur Kumar
Department of Health Policy and Management, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
1 shared publication - Akzhan Konysbekova
Research Institute of Cardiology and Internal Diseases
1 shared publication - Bakytzhan Akylbek
SE on REM “Almaty Multidisciplinary Clinical Hospital”, Almaty, Kazakhstan
1 shared publication - Dilara Nurbaeva1 shared publication
- Ermagambet Kuatbaev1 shared publication
- Margulan Uazhanov
Astana Medical University
1 shared publication
Latest Publications
- Open Access
- 3 August 2026
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 23 (4) , 103-112
Beyond Technical Innovation: Organizational and Economic Evaluation of Minimally Invasive Cardiac Surgery – a Narrative Review and Hospital-Level Framework
Background: Minimally invasive cardiac surgery (MICS) is increasingly recognized as an integrated perioperative care model rather than simply a small-incision surgical technique. Its clinical and economic value depends on patient selection, team experience, recovery pathways, institutional resources, and local cost structures. Objective: This narrative review summarizes the current evidence on the clinical, organizational, and economic value of MICS, and proposes a practical hospital-level framework for evaluating program performance and maturity. Methods: A structured narrative search of PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar was conducted between January 2010 and June 2026. The review focused on minimally invasive valve surgery, coronary revascularization, enhanced recovery pathways, programme learning curves, resource utilization, and hospital cost analyses. The conduct and reporting of the review were guided by the Scale for the Assessment of Narrative Review Articles (SANRA). Evidence was synthesized across four domains: clinical safety and effectiveness, programme maturity and learning curves, organizational performance, and economic performance. Since the review was interpretive rather than systematic, a formal duplicate-screening workflow, PRISMA flow diagram, or study-level risk-of-bias instrument was not utilized. Results: MICS can provide outcomes comparable to conventional sternotomy, with shorter intensive care and hospital stays, lower transfusion requirements, fewer wound complications, and earlier mobilization. However, higher operative costs, specialized equipment, longer cardiopulmonary bypass and cross-clamp times, peripheral cannulation risks, conversion to sternotomy, and learning-curve effects may offset postoperative savings. Economic value therefore depends on whether reduced surgical trauma translates into fewer complications and lower overall resource use. Conclusion: MICS should be evaluated as a value-based care model. Centres developing MICS programmes should monitor risk-adjusted outcomes, resource utilization, conversions, total costs and learning curve dynamics through a structured institutional registry.
- 3 August 2026
- Published by JSC National Scientific Medical Research Center in Journal of Clinical Medicine of Kazakhstan
- Vol. 23 (4) , 103-112
Open AccessBeyond Technical Innovation: Organizational and Economic Evaluation of Minimally Invasive Cardiac Surgery – a Narrative Review and Hospital-Level Framework
Background: Minimally invasive cardiac surgery (MICS) is increasingly recognized as an integrated perioperative care model rather than simply a small-incision surgical technique. Its clinical and economic value depends on patient selection, team experience, recovery pathways, institutional resources, and local cost structures. Objective: This narrative review summarizes the current evidence on the clinical, organizational, and economic value of MICS, and proposes a practical hospital-level framework for evaluating program performance and maturity. Methods: A structured narrative search of PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar was conducted between January 2010 and June 2026. The review focused on minimally invasive valve surgery, coronary revascularization, enhanced recovery pathways, programme learning curves, resource utilization, and hospital cost analyses. The conduct and reporting of the review were guided by the Scale for the Assessment of Narrative Review Articles (SANRA). Evidence was synthesized across four domains: clinical safety and effectiveness, programme maturity and learning curves, organizational performance, and economic performance. Since the review was interpretive rather than systematic, a formal duplicate-screening workflow, PRISMA flow diagram, or study-level risk-of-bias instrument was not utilized. Results: MICS can provide outcomes comparable to conventional sternotomy, with shorter intensive care and hospital stays, lower transfusion requirements, fewer wound complications, and earlier mobilization. However, higher operative costs, specialized equipment, longer cardiopulmonary bypass and cross-clamp times, peripheral cannulation risks, conversion to sternotomy, and learning-curve effects may offset postoperative savings. Economic value therefore depends on whether reduced surgical trauma translates into fewer complications and lower overall resource use. Conclusion: MICS should be evaluated as a value-based care model. Centres developing MICS programmes should monitor risk-adjusted outcomes, resource utilization, conversions, total costs and learning curve dynamics through a structured institutional registry.
- Open Access
- 30 June 2026
- Published by South Kazakhstan Medical Academy in Central Asian Journal of Medical Hypotheses and Ethics
- Vol. 7 (2) , 178-184
IMPROVED SHORT-TERM OUTCOMES FOLLOWING OPTIMIZED ACUTE MYOCARDIAL INFARCTION CARE: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY
Background: Acute myocardial infarction (AMI) remains a major cause of mortality worldwide, with outcomes strongly influenced by healthcare system organization and timely access to reperfusion therapy. Evidence from Central Asia, including Kazakhstan, remains limited, particularly regarding real-world hospital-based outcomes. Objective: To assess clinical outcomes and temporal trends in the management of AMI in a tertiary cardiac center in Almaty, Kazakhstan. Methods: A retrospective observational cohort study was conducted at the City Cardiology Center in Almaty, including all adult patients with AMI admitted between 2023 and 2025. Data were obtained from hospital databases and institutional reports. Primary outcomes included in-hospital mortality, early (24-hour) mortality, and 30-day mortality. Secondary outcomes included procedural volumes and system performance indicators. Temporal trends were analyzed across study years. Results: In-hospital mortality remained stable (1.8% in 2023–2024 vs. 1.9% in 2025), as did AMI-specific mortality (6.0% in 2024 vs. 6.1% in 2025). However, significant improvements were observed in short-term outcomes. Early mortality decreased from 69 to 60 cases (–13.0%), while 30-day mortality declined from 176 to 163 cases (–7.4%). Post-discharge mortality also decreased from 57 to 48 cases (–15.8%). Procedural volumes showed mixed trends: PCI and stenting volumes decreased, while coronary angiography volumes remained stable or slightly increased. At the same time, system performance indicators improved substantially: the proportion of patients seeking care within 60 minutes increased from 55.2% to 89.0%, and the proportion of patients undergoing PCI within 60 minutes of arrival increased from 57.2% to 70.4%. Conclusion: Improvements in healthcare system performance, particularly reduced treatment delays and optimized care pathways, were associated with better short-term outcomes in AMI patients. These findings highlight the importance of system-level interventions and provide valuable evidence for strengthening cardiovascular care in Kazakhstan and other Central Asian countries.
- 30 June 2026
- Published by South Kazakhstan Medical Academy in Central Asian Journal of Medical Hypotheses and Ethics
- Vol. 7 (2) , 178-184
Open AccessIMPROVED SHORT-TERM OUTCOMES FOLLOWING OPTIMIZED ACUTE MYOCARDIAL INFARCTION CARE: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY
Background: Acute myocardial infarction (AMI) remains a major cause of mortality worldwide, with outcomes strongly influenced by healthcare system organization and timely access to reperfusion therapy. Evidence from Central Asia, including Kazakhstan, remains limited, particularly regarding real-world hospital-based outcomes. Objective: To assess clinical outcomes and temporal trends in the management of AMI in a tertiary cardiac center in Almaty, Kazakhstan. Methods: A retrospective observational cohort study was conducted at the City Cardiology Center in Almaty, including all adult patients with AMI admitted between 2023 and 2025. Data were obtained from hospital databases and institutional reports. Primary outcomes included in-hospital mortality, early (24-hour) mortality, and 30-day mortality. Secondary outcomes included procedural volumes and system performance indicators. Temporal trends were analyzed across study years. Results: In-hospital mortality remained stable (1.8% in 2023–2024 vs. 1.9% in 2025), as did AMI-specific mortality (6.0% in 2024 vs. 6.1% in 2025). However, significant improvements were observed in short-term outcomes. Early mortality decreased from 69 to 60 cases (–13.0%), while 30-day mortality declined from 176 to 163 cases (–7.4%). Post-discharge mortality also decreased from 57 to 48 cases (–15.8%). Procedural volumes showed mixed trends: PCI and stenting volumes decreased, while coronary angiography volumes remained stable or slightly increased. At the same time, system performance indicators improved substantially: the proportion of patients seeking care within 60 minutes increased from 55.2% to 89.0%, and the proportion of patients undergoing PCI within 60 minutes of arrival increased from 57.2% to 70.4%. Conclusion: Improvements in healthcare system performance, particularly reduced treatment delays and optimized care pathways, were associated with better short-term outcomes in AMI patients. These findings highlight the importance of system-level interventions and provide valuable evidence for strengthening cardiovascular care in Kazakhstan and other Central Asian countries.